BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/13/2019 6:00:06 AM | Browse: 816 | Download: 1465
 |
Received |
|
2018-11-09 02:25 |
|
Peer-Review Started |
|
2018-11-12 02:26 |
|
To Make the First Decision |
|
2019-01-31 07:07 |
|
Return for Revision |
|
2019-01-31 07:54 |
|
Revised |
|
2019-02-26 16:41 |
|
Second Decision |
|
2019-03-01 07:44 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-03-02 03:44 |
|
Articles in Press |
|
2019-03-02 03:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-04-04 01:53 |
|
Publish the Manuscript Online |
|
2019-04-13 06:00 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ignacio Alfaro, Maria Carme Masamunt, Nuria Planell, Alicia López-García, Jesús Castro, Marta Gallego, Rebeca Barastegui, Angel Giner, Alejandro Vara, Azucena Salas, Elena Ricart, Julián Panés and Ingrid Ordás |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Helmsley Charitable Trust |
2015PG-IBD005 |
|
| Corresponding Author |
Ingrid Ordás, MD, PhD, Staff Physician, Gastroenterology Department, Hospital Clínic de Barcelona, Villarroel 170, Barcelona 08036, Spain. iordas@clinic.cat |
| Key Words |
Crohn’s disease; Endoscopy; Mucosal healing; Crohn’s Disease Endoscopic Index of Severity; Tumor necrosis factor |
| Core Tip |
In our study we report that endoscopic response after completion of induction treatment with a tumor necrosis factor inhibitor predicts mucosal healing at long term in patients with Crohn’s disease, and that endoscopic evaluation at this time point may be considered in clinical practice to predict long term outcomes and could contribute to perform treatment adjustments. |
| Publish Date |
2019-04-13 06:00 |
| Citation |
Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i14.1764 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
